Edwards Lifesciences
1,239 hedge funds and large institutions have $37.2B invested in Edwards Lifesciences in 2023 Q4 according to their latest regulatory filings, with 171 funds opening new positions, 376 increasing their positions, 497 reducing their positions, and 131 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 1,215 → 1,239 (+24)
0.76% less ownership
Funds ownership: 80.93% → 80.17% (-0.76%)
24% less repeat investments, than reductions
Existing positions increased: 376 | Existing positions reduced: 497
Holders
1,239
Holding in Top 10
9
Calls
$336M
Puts
$232M
Top Buyers
| 1 | +$356M | |
| 2 | +$306M | |
| 3 | +$301M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$212M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$159M |
Top Sellers
| 1 | -$1.48B | |
| 2 | -$254M | |
| 3 | -$117M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$92.9M |
| 5 |
CIM
CCLA Investment Management
London,
United Kingdom
|
-$89.1M |